Grigorios T. Sakellariou
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Grigorios T. Sakellariou has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
Charalampos Berberidis
General Military Hospital, Thessaloniki, Greece
2 shared publicationsAleksandros Mpoumponaris
1 shared publicationDimitrios Karanikolas
General Military Hospital, Thessaloniki, Greece
1 shared publicationEpaminondas Molyvas
1 shared publicationGeorge A. Kapetanos
Papageorgiou General Hospital, Thessaloniki, Greece
1 shared publicationGeorgios Kouklakis
1 shared publication
Latest Publications
- 31 August 2011
- Published by Wiley in Arthritis & Rheumatism
- Vol. 63 (9) , 2743
Clinical Images: Extensive calcinosis in lupus panniculitis
- 31 August 2011
- Published by Wiley in Arthritis & Rheumatism
- Vol. 63 (9) , 2743
Clinical Images: Extensive calcinosis in lupus panniculitis
- 1 December 2006
- Published by Elsevier in Joint Bone Spine
- Vol. 73 (6) , 725-728
Bone density in young males with recently diagnosed inflammatory bowel disease
- 1 December 2006
- Published by Elsevier in Joint Bone Spine
- Vol. 73 (6) , 725-728
Bone density in young males with recently diagnosed inflammatory bowel disease
- Open Access
- 18 October 2005
- Published by Oxford University Press (OUP) in Rheumatology
- Vol. 44 (12) , 1588-1590
Infliximab infusions for persistent back pain in two patients with Schmorl's nodes
Sir, Schmorl's nodes (SNs) are herniations of the nucleus pulposus (NP) material through the vertebral endplates into the trabecular bone. SNs are the most common non-intervertebral disc abnormalities in magnetic resonance imaging (MRI) in persons without back pain [1]. However, SNs are seldom symptomatic, and treatment with analgesics, non-steroidal anti-inflammatory drugs (NSAIDs) or corticosteroids usually improves back pain. In contrast to SNs, herniated intervertebral discs (HIDs) are a common cause of back and radicular pain. TNF-α from the NP does appear to be pathogenic to nerve roots in animal models of sciatica [2]. Furthermore, TNF-α blockade is effective in preventing NP-induced functional and structural nerve root injury in animal models [3]. The efficacy of the TNF-α inhibitors infliximab and etanercept in leg and back pain has recently been shown in patients with HID-induced sciatica [4, 5]. These results of TNF-α blockade prompted us to test infliximab infusions for refractory symptoms to conventional conservative treatment in two patients with painful SN.
- 18 October 2005
- Published by Oxford University Press (OUP) in Rheumatology
- Vol. 44 (12) , 1588-1590
Open AccessInfliximab infusions for persistent back pain in two patients with Schmorl's nodes
Sir, Schmorl's nodes (SNs) are herniations of the nucleus pulposus (NP) material through the vertebral endplates into the trabecular bone. SNs are the most common non-intervertebral disc abnormalities in magnetic resonance imaging (MRI) in persons without back pain [1]. However, SNs are seldom symptomatic, and treatment with analgesics, non-steroidal anti-inflammatory drugs (NSAIDs) or corticosteroids usually improves back pain. In contrast to SNs, herniated intervertebral discs (HIDs) are a common cause of back and radicular pain. TNF-α from the NP does appear to be pathogenic to nerve roots in animal models of sciatica [2]. Furthermore, TNF-α blockade is effective in preventing NP-induced functional and structural nerve root injury in animal models [3]. The efficacy of the TNF-α inhibitors infliximab and etanercept in leg and back pain has recently been shown in patients with HID-induced sciatica [4, 5]. These results of TNF-α blockade prompted us to test infliximab infusions for refractory symptoms to conventional conservative treatment in two patients with painful SN.